[  1] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[  2] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[  3] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[  4] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[  5] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[  6] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[  7] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[  8] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[  9] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 10] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 11] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 12] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 13] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 14] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 15] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 16] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 17] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 19] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 20] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 21] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 22] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 23] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 25] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 26] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 27] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 28] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 29] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 31] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 32] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 33] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 34] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 35] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 36] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 37] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 38] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 39] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 40] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 41] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 42] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 43] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 44] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 46] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 47] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 48] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 49] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 50] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 51] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 52] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 53] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 55] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 56] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 57] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 58] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 59] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[ 60] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 61] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 62] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 63] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 64] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 66] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 67] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 68] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 69] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 70] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[ 71] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 72] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 73] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 74] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 75] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 77] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 78] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 79] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 80] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 81] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[ 82] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 83] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 84] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 85] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 86] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[ 87] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 88] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[ 90] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 91] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 92] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[ 93] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 94] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[ 95] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 96] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 97] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[ 98] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 99] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[100] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[101] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[102] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[103] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[104] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[105] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[106] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[107] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[108] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[109] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[110] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[111] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[112] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[113] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[114] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[116] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[117] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[118] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[119] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[120] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[121] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[122] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[123] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[124] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[125] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[126] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[127] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[128] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[129] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[130] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[131] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[132] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[133] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[134] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[135] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[136] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[137] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[138] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[139] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[140] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[141] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[142] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[143] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[145] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[146] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[147] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[148] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[149] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[150] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[151] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[152] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[153] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[154] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[155] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[156] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[157] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[158] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[159] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[160] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[161] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[163] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[164] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[165] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[166] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[167] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[168] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[169] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[170] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[171] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[172] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[173] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[174] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[175] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[176] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[177] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[178] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[179] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[181] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[182] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[183] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[184] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[185] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[186] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[187] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[188] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[189] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[190] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[191] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[192] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[193] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[194] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[195] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[196] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[197] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[198] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[200] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[201] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[202] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[203] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[204] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[205] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[206] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[207] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[208] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[209] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[210] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[211] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[212] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[213] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[214] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[215] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[216] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[217] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[219] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[220] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[221] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[222] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[223] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[224] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[225] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[226] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[227] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[228] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[229] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[230] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[231] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[235] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[236] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[237] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[238] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[239] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[241] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[242] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[243] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[244] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[245] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[246] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[247] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[248] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[249] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[250] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[251] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[252] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[253] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[257] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[258] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[259] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[260] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[261] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[262] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[263] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[264] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[265] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[266] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[267] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[268] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[269] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[270] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[271] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[272] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[273] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[274] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[275] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[280] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[281] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[282] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[283] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[284] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[286] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[287] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[288] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[289] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[290] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[291] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[292] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[293] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[294] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[295] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[296] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[297] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[298] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[303] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[304] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[305] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[306] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[307] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[308] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[310] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[311] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[312] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[313] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[314] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[315] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[316] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[317] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[318] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[319] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[320] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[321] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[322] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[323] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[325] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[326] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[328] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[329] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[330] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[331] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[332] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[333] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[334] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[335] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[336] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[337] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[338] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[339] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[340] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[341] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[342] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[343] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[344] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[345] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[346] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[347] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[348] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[349] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[350] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[353] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[354] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[355] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[356] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[357] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[358] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[359] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[360] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[361] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[362] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[363] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[364] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[365] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[366] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[367] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[368] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[369] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[370] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[371] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[372] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[374] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[375] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[376] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[378] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[381] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[382] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[383] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[384] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[385] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[387] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[388] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[389] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[390] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[391] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[392] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[393] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[394] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[395] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[396] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[397] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[398] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[399] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[405] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[408] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[409] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[410] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[411] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[412] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[413] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[414] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[415] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[416] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[417] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[418] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[419] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[420] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[421] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[422] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[423] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[424] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[425] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[426] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[427] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[428] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[429] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[430] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[435] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[438] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[439] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[441] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[442] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[443] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[444] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[445] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[446] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[447] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[448] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[449] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[450] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[451] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[452] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[453] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[454] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[455] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[456] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[457] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[458] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[459] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[465] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[467] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[468] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[470] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[471] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[472] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[473] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[474] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[475] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[476] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[477] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[478] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[479] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[480] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[481] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[482] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[483] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[484] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[485] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[486] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[487] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[488] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[489] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[490] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[491] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[492] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[494] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[495] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[496] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[497] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[498] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[499] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[500] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[502] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[503] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[504] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[505] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[506] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[507] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[508] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[509] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[510] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[511] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[512] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[513] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[514] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[515] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[516] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[517] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[518] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[519] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[520] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[521] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[522] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[524] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[525] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[526] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[527] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[528] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[529] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[530] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[531] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[532] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[533] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[534] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[535] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[536] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[537] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[538] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[539] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[540] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[541] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[542] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[543] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[545] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[546] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[547] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[548] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[549] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[550] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[551] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[552] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[553] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[554] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[555] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[556] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[557] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[558] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[559] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[561] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[562] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[563] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[564] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[565] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[566] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[567] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[568] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[569] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[570] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[571] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[572] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[573] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[574] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[575] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[576] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[577] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[578] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[579] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[580] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[581] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[582] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[583] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[584] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[585] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[586] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[587] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[588] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[589] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[590] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[591] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[592] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[593] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[594] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[595] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[596] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[597] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[598] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[599] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[600] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[602] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[603] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[604] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[605] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[606] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[607] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[608] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[609] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[610] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[611] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[612] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[613] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[614] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[615] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[616] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[617] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[618] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[619] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[620] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[621] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[622] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[623] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[624] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[625] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[626] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[627] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[628] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[629] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[630] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[631] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[633] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[634] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[635] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[636] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[637] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[638] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[639] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[640] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[641] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[642] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[643] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[645] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[646] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[647] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[648] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[649] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[650] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[651] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[652] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[653] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[654] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[655] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[656] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[657] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[658] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[659] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[660] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[661] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[662] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[663] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[664] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[665] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[666] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[667] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[668] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[669] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[671] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[672] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[673] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[674] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[675] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[676] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[677] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[678] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[679] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[680] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[681] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[682] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[683] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[684] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[685] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[686] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[687] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[688] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[689] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[690] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[691] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[692] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[693] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[694] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[696] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[697] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[698] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[699] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[700] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[701] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[702] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[703] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[704] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[705] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[706] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[707] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[708] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[709] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[713] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[714] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[715] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[716] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[717] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[718] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[719] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[720] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[721] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[722] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[723] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[724] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[725] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[726] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[727] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[728] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[729] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[730] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[731] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[732] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[733] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[735] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[736] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[737] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[738] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[739] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[740] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[741] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[742] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[743] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[744] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[745] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[746] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[747] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[748] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[749] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[750] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[751] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[752] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[753] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[754] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[755] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[756] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[757] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[758] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[759] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[760] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[761] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[762] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[763] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[764] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[765] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[766] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[767] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[768] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[769] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[770] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[771] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[772] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[773] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[774] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[775] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[776] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[777] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[778] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[779] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[780] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[781] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[782] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[783] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[784] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[785] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[786] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[787] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[788] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[789] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[790] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[791] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[792] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[793] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[794] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[795] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[796] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[797] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[798] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[799] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[801] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[802] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[803] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[804] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[806] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[807] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[808] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[809] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[810] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[811] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[812] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[813] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[814] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[815] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[816] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[817] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[818] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[819] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[820] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[821] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[822] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[823] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[824] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[825] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[826] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[827] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[828] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[829] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[830] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[831] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[832] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[833] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[834] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[835] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[836] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[837] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[838] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[839] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[840] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[841] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[842] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[843] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[844] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[845] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[846] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[847] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[848] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[849] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[850] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[851] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[852] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[853] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[854] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[855] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[856] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[857] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[858] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[859] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[860] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[861] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[862] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[863] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[864] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[865] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[866] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[867] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[868] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[869] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[870] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[871] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[872] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[873] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[874] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[875] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[876] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[877] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[878] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[879] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[880] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[881] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[882] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[883] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[884] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[885] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[886] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[887] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[888] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[889] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[890] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[891] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[892] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[893] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[894] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[895] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[896] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[897] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[898] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[899] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[900] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[901] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[902] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[903] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[904] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[905] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[906] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[907] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[908] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[909] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[910] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[911] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[912] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[913] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[914] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[915] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[916] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[917] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[918] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[919] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[920] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[921] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[922] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[923] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[924] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[925] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[926] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[927] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[928] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[929] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[930] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[931] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[932] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[933] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[934] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[935] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[936] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[937] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[938] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[939] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[940] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[941] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[942] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[943] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[944] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[945] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[946] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[947] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[948] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[949] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[950] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[951] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[952] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[953] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[954] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[955] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[956] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[957] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[958] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[959] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[960] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[961] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[962] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[963] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[964] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[965] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[966] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[967] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[968] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[969] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[970] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[971] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[972] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[973] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[974] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[975] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[976] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[977] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[978] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[979] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[980] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[981] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[982] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[983] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[984] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[985] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[986] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[987] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[988] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[989] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[990] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[991] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[992] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[993] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[994] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[995] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[996] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[997] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[998] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[999] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1000] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1001] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1002] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1003] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1004] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1005] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1006] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1007] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1008] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1009] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1010] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1011] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1012] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1013] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1014] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1015] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1016] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1017] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1018] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1019] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1020] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1021] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1022] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1023] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1024] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1025] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1026] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1027] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1028] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1029] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1030] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1031] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1032] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1033] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1034] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1035] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1036] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1037] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1038] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1039] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1040] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1041] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1042] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1043] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1044] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1045] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1046] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1047] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1048] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1049] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1050] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1051] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1052] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1053] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1054] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1055] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1056] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1057] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1058] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1059] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1060] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1061] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1062] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1063] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1064] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1065] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1066] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1067] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1068] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1069] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1070] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1071] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1072] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1073] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1074] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1075] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1076] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1077] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1078] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1079] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1080] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1081] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1082] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1083] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1084] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1085] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1086] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1087] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1088] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1089] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1090] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1091] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1092] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1093] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1094] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1095] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1096] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1097] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1098] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1099] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1100] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1102] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1103] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1104] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1105] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1109] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1110] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1111] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1112] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1113] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1114] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1115] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1116] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1117] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1118] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1119] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1120] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1122] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1123] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1124] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1125] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1126] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1127] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1128] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1129] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1130] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1131] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1132] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1133] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1134] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1140] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1143] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1146] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1147] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1148] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1149] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1150] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1151] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1152] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1154] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1155] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1157] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1158] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1159] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1161] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1162] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1163] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1164] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1165] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1166] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1167] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1168] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1169] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1170] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1171] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1172] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1173] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1174] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1175] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1176] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1177] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1178] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1179] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1180] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1181] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1183] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1184] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1185] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1186] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1187] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1188] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1190] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1193] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1194] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1196] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1197] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1198] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1199] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1200] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1204] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1205] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1206] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1208] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1209] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1211] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1212] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1213] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1214] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1215] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1216] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1218] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1219] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1220] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1221] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1222] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1223] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1224] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1225] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1226] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1227] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1228] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1229] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1230] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1231] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1236] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1237] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1238] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1239] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1242] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1243] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1244] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1245] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1246] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1247] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1248] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1253] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1254] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1255] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1257] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1258] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1260] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1261] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1262] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1263] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1264] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1265] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1266] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1268] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1269] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1270] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1271] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1272] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1273] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1274] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1275] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1276] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1277] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1278] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1279] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1280] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1281] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1282] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1286] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1288] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1289] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1290] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1292] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1293] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1295] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1296] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1297] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1298] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1303] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1304] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1305] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1306] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1307] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1308] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1310] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1313] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1314] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1315] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1316] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1317] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1319] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1320] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1321] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1322] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1323] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1324] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1325] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1326] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1327] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1328] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1329] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1330] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1331] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1333] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1334] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1335] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1336] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1337] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1338] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1339] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1340] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1343] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1344] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1345] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1346] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1347] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1348] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1349] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1350] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1353] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1354] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1355] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1356] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1357] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1358] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1359] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1360] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1364] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1365] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1366] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1367] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1368] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1369] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1370] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1371] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1372] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1373] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1374] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1375] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1376] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1377] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1378] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1379] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1380] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1381] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1382] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1383] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1384] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1385] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1387] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1388] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1389] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1390] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1391] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1394] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1395] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1396] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1397] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1398] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1399] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1400] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1405] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1406] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1407] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1409] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1410] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1411] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1412] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1413] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1414] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1415] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1416] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1417] Press Release (2026-04-04)/Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".
[1418] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1419] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1421] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1422] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1423] Investor Presentation (2026-02-24)/Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation
[1424] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1425] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1426] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1427] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1428] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1429] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1430] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1431] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1432] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1433] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1438] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1439] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1441] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1442] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1443] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1444] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1445] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1446] Investor Presentation (2026-01-13)/Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation
[1447] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1448] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1449] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1450] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1451] Press Release (2026-02-05)/Sai Life Sciences Limited has informed the Exchange regarding Press release for the Un-audited Financial Results for the quarter and nine months ended on 31 December 2025.".
[1452] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1453] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1454] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1456] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1457] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1458] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1459] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1460] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1461] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript